Notes archive.
Tahmar approves FY26 results but doesn't disclose any numbers
A procedural filing under SEBI rules. The board signed off, but the financials are absent.
Greenhitech raised ₹89.61 cr. The acquisitions doubled revenue and halved profit.
Two new subsidiaries made the top line bigger but ate all the earnings. The standalone business was flat.
Rama Steel profit slumps 67% in Q4, tax authority proposes ₹71.96 cr assessment
A weak quarter and a draft tax order overshadow a full year where revenue grew 14% but profit barely moved.
Mudunuru demands ₹12 cr from a client. Its annual loss is widening.
The nano-cap IT firm's revenue slumped 48% in FY26. A claim for ₹12.05 crore against Infronics Systems now dwarfs its core business.
Wagend Infra's audited FY26 results are out, but the numbers were already known.
A procedural filing of balance sheets and auditor reports adds nothing to the revenue and profit figures disclosed earlier.
EPack's VP Operations resigns, leaving a gap at the micro-cap manufacturer
Potluri Venkata Subbarao has stepped down from his role overseeing day-to-day production and capacity expansion. No reason was given.
Wagend Infra's revenue jumps 41x, but from a ₹5.80 lakh base
FY26 audited revenue hit ₹243.02 lakh, a massive percentage surge on negligible prior-year earnings. The company's market cap is ₹5 crore.
Centenial Surgical Suture posts a ₹2.2 cr annual loss on flat revenue
A ₹2.31 crore fourth-quarter loss wiped out the small profit earned through the first nine months. Full-year revenue held flat at ₹53.84 crore.
Avishkar Infra's FY26 revenue is ₹200 lakh. Its market cap is ₹1,363 crore.
A profitable standalone business is overwhelmed by group losses, creating a stark valuation mismatch.
Centenial Surgical Suture posts FY26 results, auditors sign off clean
A routine annual filing for a nano-cap company. The auditors gave an unmodified opinion, but the results carry no strategic surprises.
Oriental Trimex posts lower revenue and profit for FY26
A nano-cap with a ₹47 crore market cap reported routine results, showing a slight revenue decline and a sharp drop in net profit after exceptional items faded.
Ganesha Ecoverse's profit is a ₹780L accounting reversal, not earnings
A one-off gain from unwinding preference-dividend liability flips the standalone bottom line. Consolidated losses are still ₹520.74L.
Newtime Infrastructure's FY26 loss widens as auditor flags ED attachment
A consolidated net loss of ₹541.80 lakh caps a year where the auditor attached a caveat to the results.
Bhagwati Autocast profit more than doubles to ₹1,131 lakhs
FY26 net profit jumped from ₹617 lakhs, driven by higher casting revenue. The board also brought in a former Kotak Mahindra executive and a new auditor.
Karbonsteel is shutting its Khopoli plant. No buyer, no capital recovery.
The nano-cap closed the underperforming unit at a board meeting that also approved its FY26 results. The plant contributed ₹11 crore, or 3.66% of total turnover.
Gajanan Securities audited results are clean. The profit is almost nothing.
A routine compliance filing from a ₹16 crore company. Q4 net profit was ₹0.66 lakh.
Indian Wood Products profit dips even as revenue ticks up
A ₹228-lakh revenue gain was more than offset by a smaller profit. The dividend is unchanged.
Oriental Trimex files FY26 results. They change nothing.
A nano-cap's routine annual audit. Revenue of ₹24.62 crore, profit of ₹1.79 crore, and zero new information.
Anuroop Packaging's profit fell 72% as revenue slipped 21%
Full-year net profit dropped to ₹17.74 lakh from ₹62.40 lakh, a steep margin hit for the nano-cap packaging firm.
United Van Der Horst profit climbs 20% on flat revenue
The nano-cap logistics firm posted ₹5.22 cr profit on ₹31.94 cr revenue for FY26. The audit was clean.
Tulsyan NEC auditor flags ₹76 cr receivables; director resigns
A recurring audit qualification on 59.5% of trade receivables and a whole-time director's exit deepen governance questions at the loss-making nano-cap.
Gabriel Pet Straps revenue explodes 475% after pharma acquisition
Standalone revenue surged to ₹177 crore in FY26. A new subsidiary bought 95% of Drug Centre's business in March, but its full impact is yet to be felt.
Wockhardt's ZAYNICH wins FDA approval, first novel drug from an Indian pharma
The antibiotic beat meropenem in a 530-patient trial, validating a 15-year R&D pivot and opening a US market with 600,000+ annual hospitalisations.
SSMD Agrotech posts 16% revenue growth, profit barely moves
The nano-cap's top line grew to ₹11,535 lakhs in FY25, but the bottom line added just ₹15 lakh.
Jeena Sikho profit jumps 178% to ₹222 cr as costs lag revenue surge
Annual revenue grew 71% to ₹801 crore, but expenses rose only 39%. The board recommended a ₹4.50 per share final dividend.